HERA FIb Registry for Patients With Atrial Fibrillation

NCT05995561 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12297

Last updated 2024-05-09

No results posted yet for this study

Summary

The single-center HERA AFIb registry was created to assess real-world prevalence, demographic characteristics and management of patients with atrial fibrillation (AF) in the era of novel oral anticoagulant regimes (NOAC) presenting in the emergency department (ED) of University of Heidelberg

Conditions

Interventions

OTHER

no intervention is planned.

no intervention is planned.

Sponsors & Collaborators

  • University Hospital Heidelberg

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-01
Primary Completion
2020-04-01
Completion
2020-04-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05995561 on ClinicalTrials.gov